Brian T. Powl

Filings by Brian T. Powl span 2 companies, the busiest being Kura Oncology, Inc. and Fate Therapeutics Inc. In total, 16 filings cover trades dated from 27 June 2022 to 29 September 2026.

Sales make up the whole of the open-market record (10 sales, €575k). The rest of the record consists of 6 share grants. In 2026 alone, the filings show no purchases and 6 sales.

The latest filing, published on 29 September 2026, reports an open-market sale of €74k in Kura Oncology, Inc. Typically, a trade is published a median of 1 day after it takes place. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.